Question 1

How to Verify Peptide Purity: HPLC, Mass Spec, and COA Review

Accepted Answer

Researchers verify peptide purity using two primary analytical techniques: HPLC (high-performance liquid chromatography) to quantify the percentage of the target compound in the preparation, and mass spectrometry (MS) to confirm that the compound matches the expected sequence. These two methods together answer the two essential questions: how pure is it, and is it actually the right compound?

Question 2

Reading an HPLC Chromatogram

Accepted Answer

HPLC purity is reported as the percentage of the target peptide's peak area relative to total peak area in the UV chromatogram, typically measured at 214nm or 220nm. A purity of 98% or above is the standard for research-grade material. When reviewing a COA, look at the actual chromatogram image, not just the purity number. A chromatogram with a single dominant peak and essentially flat baseline on either side is a good sign. Multiple visible peaks, particularly those close in retention time to the main peak, indicate related peptide impurities, possibly truncated sequences or amino acid deletion products from synthesis. Those impurities matter in receptor binding assays where even small concentrations of related compounds can add noise.

Question 3

What Mass Spectrometry Adds

Accepted Answer

HPLC doesn't confirm compound identity with certainty. A different peptide with similar hydrophobicity could elute at the same retention time and produce a similar chromatogram. Mass spectrometry resolves this by measuring the molecular weight of the dominant compound. If the measured mass matches the theoretical mass of your target peptide (to within instrument tolerance, typically less than 1 Da for standard ESI-MS), you have identity confirmation. For modifications like C-terminal amidation or acetylation, confirm the mass spec data reflects the expected modification. An amidated peptide has a different molecular weight than the free acid form, and that difference should be visible in the MS spectrum.

Question 4

Third-Party vs In-House Testing

Accepted Answer

The distinction between third-party and in-house COAs matters for research validity. A COA generated by an independent analytical laboratory carries more weight than one generated by the supplier's own QC department. Independent labs have no incentive to pass a failing sample, and their methods are subject to independent calibration and accreditation. When evaluating a supplier's documentation, check whether the COA header identifies the testing laboratory separately from the peptide supplier. If the same company name appears in both places, that's in-house testing. Spartan Peptides uses independent analytical laboratories for all lot-specific testing.

Question 5

Additional Verification Methods

Accepted Answer

For especially sensitive research applications, researchers may request amino acid analysis (AAA), which quantifies the actual molar ratios of each amino acid in the peptide after hydrolysis, providing an independent check on both sequence composition and concentration. This goes beyond standard COA testing and is worth considering for foundational studies where compound characterization is itself a research output.

Question 6

Where can I find real-world examples of verified peptide COAs?

Accepted Answer

Spartan Peptides publishes the original third-party Certificates of Analysis from MZ Biolabs for its tested compounds at spartanpeptides.com/quality-assurance/coa/. Each page includes the HPLC chromatogram, purity percentage, mass spectrometry data, lot number, and analysis date. These serve as reference examples of what independent batch-specific COA documentation should contain for research-grade peptides.

GLP-3(Reta) | Triple-Agonist Metabolic Research

NAD+ 750mg | Cellular Energy & DNA Repair Research

MOTS-c | Mitochondrial Metabolism Research Peptide

BPC-157 5mg | Tissue Repair & Gut Health Research

How to Verify Peptide Purity Frequently Asked Questions

Explore Full Research Index